Barbara J. McDermott

2.3k total citations
84 papers, 1.9k citations indexed

About

Barbara J. McDermott is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Barbara J. McDermott has authored 84 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 27 papers in Cellular and Molecular Neuroscience and 24 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Barbara J. McDermott's work include Neuropeptides and Animal Physiology (24 papers), Receptor Mechanisms and Signaling (21 papers) and Nitric Oxide and Endothelin Effects (13 papers). Barbara J. McDermott is often cited by papers focused on Neuropeptides and Animal Physiology (24 papers), Receptor Mechanisms and Signaling (21 papers) and Nitric Oxide and Endothelin Effects (13 papers). Barbara J. McDermott collaborates with scholars based in United Kingdom, Slovakia and United States. Barbara J. McDermott's co-authors include David Bell, Elizabeth J. Kelso, Youyou Zhao, David Grieve, Emma Robinson, Bernard Silke, Adam Harvey, Brian D. Green, Michelle B. Hookham and Ajay M. Shah and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Virology.

In The Last Decade

Barbara J. McDermott

83 papers receiving 1.8k citations

Peers

Barbara J. McDermott
Ralf Mrowka Germany
Junhui Zhang United States
Amit Berson United States
Che‐Hong Chen United States
Swati Banerjee United States
M G Collis United Kingdom
Ralf Mrowka Germany
Barbara J. McDermott
Citations per year, relative to Barbara J. McDermott Barbara J. McDermott (= 1×) peers Ralf Mrowka

Countries citing papers authored by Barbara J. McDermott

Since Specialization
Citations

This map shows the geographic impact of Barbara J. McDermott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara J. McDermott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara J. McDermott more than expected).

Fields of papers citing papers by Barbara J. McDermott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara J. McDermott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara J. McDermott. The network helps show where Barbara J. McDermott may publish in the future.

Co-authorship network of co-authors of Barbara J. McDermott

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara J. McDermott. A scholar is included among the top collaborators of Barbara J. McDermott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara J. McDermott. Barbara J. McDermott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harvey, Adam, Emma Robinson, Kevin Edgar, et al.. (2020). Downregulation of PPARα during Experimental Left Ventricular Hypertrophy is Critically Dependent on Nox2 NADPH Oxidase Signalling. International Journal of Molecular Sciences. 21(12). 4406–4406. 12 indexed citations
2.
Robinson, Emma, Mitchel Tate, Sam Lockhart, et al.. (2016). Metabolically-inactive glucagon-like peptide-1(9–36)amide confers selective protective actions against post-myocardial infarction remodelling. Cardiovascular Diabetology. 15(1). 65–65. 30 indexed citations
3.
Tate, Mitchel, Emma Robinson, Brian D. Green, Barbara J. McDermott, & David Grieve. (2015). Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages. Basic Research in Cardiology. 111(1). 1–1. 87 indexed citations
4.
Zhao, Youyou, Emma Robinson, Adam Harvey, et al.. (2010). Nox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy. Cancer Research. 70(22). 9287–9297. 204 indexed citations
5.
Green, Brian D., et al.. (2010). Inward rectifier potassium channels in the HL‐1 cardiomyocyte‐derived cell line. Journal of Cellular Physiology. 225(3). 751–756. 9 indexed citations
6.
Bell, David, Malcolm Campbell, Xuanhui Wang, et al.. (2010). Adrenomedullin Gene Delivery is Cardio-protective in a Model of Chronic Nitric Oxide Deficiency Combining Pressure Overload, Oxidative Stress and Cardiomyocyte Hypertrophy. Cellular Physiology and Biochemistry. 26(3). 383–394. 17 indexed citations
8.
McDermott, Barbara J., Elizabeth J. Kelso, Paul Spiers, et al.. (2007). Protection of cardiomyocyte function by propofol during simulated ischemia is associated with a direct action to reduce pro-oxidant activity. Journal of Molecular and Cellular Cardiology. 42(3). 600–608. 20 indexed citations
9.
McDermott, Barbara J. & D. Bell. (2007). NPY and Cardiac Diseases. Current Topics in Medicinal Chemistry. 7(17). 1692–1703. 51 indexed citations
10.
Allen, Adrian, et al.. (2006). Modulation of Contractile Function through Neuropeptide Y Receptors during Development of Cardiomyocyte Hypertrophy. Journal of Pharmacology and Experimental Therapeutics. 319(3). 1286–1296. 18 indexed citations
11.
Bell, David, et al.. (2004). Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat. Cardiovascular Pathology. 13(2). 71–78. 45 indexed citations
12.
Bell, David, et al.. (2002). Temporal dependence of the onset of parameters of cardiomyocyte hypertrophy in response to pressure overload. Journal of Molecular and Cellular Cardiology. 34. 1 indexed citations
13.
Murray, Fiona, David Bell, Elizabeth J. Kelso, B. Cherie Millar, & Barbara J. McDermott. (2001). Positive and Negative Contractile Effects of Somatostatin-14 on Rat Ventricular Cardiomyocytes. Journal of Cardiovascular Pharmacology. 37(3). 324–332. 10 indexed citations
15.
Bell, David, B. Cherie Millar, & Barbara J. McDermott. (1997). Use of d‐myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C. British Journal of Pharmacology. 122(8). 1655–1660. 3 indexed citations
16.
Spiers, Paul, Elizabeth J. Kelso, Barbara J. McDermott, C. Norman Scholfield, & Bernard Silke. (1996). Endothelin‐1 mediated inhibition of the acetylcholine‐activated potassium current from rabbit isolated atrial cardiomyocytes. British Journal of Pharmacology. 119(7). 1427–1437. 7 indexed citations
17.
Gelmon, Karen A., Sean OʼReilly, Anthony W. Tolcher, et al.. (1996). Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer.. Journal of Clinical Oncology. 14(4). 1185–1191. 54 indexed citations
18.
Kelso, Elizabeth J., Barbara J. McDermott, & Bernard Silke. (1995). Actions of the Novel Vasodilator, Flosequinan, in Isolated Ventricular Cardiomyocytes. Journal of Cardiovascular Pharmacology. 25(3). 376–386. 18 indexed citations
19.
Kelso, Elizabeth J., Barbara J. McDermott, & Bernard Silke. (1993). Cardiotonic actions of selective phosphodiesterase inhibitors in rat isolated ventricular cardiomyocytes. British Journal of Pharmacology. 110(4). 1387–1394. 14 indexed citations
20.
Millar, B. Cherie, et al.. (1992). NPY-(18–36) and Pertussis Toxin Distinguish between the Negative and Positive Contractile Effects of Neuropeptide Y (NPY) in Ventricular Cardiomyocytes. Advances in experimental medicine and biology. 311. 325–326. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026